Device Heart Valves

Cg Future

Payments companies reported to CMS as associated with Cg Future. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$326Kassociated payments (2023-2025)
241clinicians with associated payments
1company reporting

By year

2023 $189K
2024 $72K
2025 $65K

Payments reported as associated with Cg Future, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Thoracic Surgery (Cardiothoracic Vascular Surgery) $310K
Cardiovascular Disease $4,510
Interventional Cardiology $2,759
Clinical Cardiac Electrophysiology $1,696
Anesthesiology $1,611
Physician Assistant $1,588

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Cg Future

These are the largest totals companies reported as associated with Cg Future. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Aubrey Galloway New York, NY Thoracic Surgery (Cardiothoracic Vascular Surgery) $230,476.00
Eugene Grossi New York, NY Thoracic Surgery (Cardiothoracic Vascular Surgery) $50,572.98
Michael Halkos Atlanta, GA Thoracic Surgery (Cardiothoracic Vascular Surgery) $9,416.32
Tessa Watt Ann Arbor, MI Thoracic Surgery (Cardiothoracic Vascular Surgery) $7,200.00
Michael Moront Toledo, OH Thoracic Surgery (Cardiothoracic Vascular Surgery) $4,562.09
Bob Kiaii Sacramento, CA Thoracic Surgery (Cardiothoracic Vascular Surgery) $2,250.00
Charles Cole Little Rock, AR Thoracic Surgery (Cardiothoracic Vascular Surgery) $1,850.18
Kevin Lodge Toledo, OH Anesthesiology $1,600.00
Vinay Badhwar Morgantown, WV Thoracic Surgery (Cardiothoracic Vascular Surgery) $1,502.86
Tara Collins New York, NY Physician Assistant $772.90

Prescribed Cg Future?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.